引用次数
引用: 23,645
H-指数: 62
I10-指数 : 201
出版物: 518
Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
Geesiena Hospers , Nanno Mulder , Wta Van Der Graaf , P Nieboer
Anticancer Research 21 3115 -3116
1
2001
5FU and oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patients
Geesiena Hospers , Nanno Mulder , O Reerink , Bernard Szabo
Anticancer Research 24 1969 -1971
4
2004
Renal failure after treatment with interferon alpha 2b.
Geesiena Hospers , de Elisabeth G. E. Vries , Wwh Roeloffzen , Gerarda Navis
Anticancer Research 22 ( 3) 1929 -1931
2
2002
Effect of specific or random c-DNA priming on sensitivity of tyrosinase nested RT-PCR: potential clinical relevance.
Hetty Timmer-Bosscha , Geesiena Hospers , A Calogero , Nanno Mulder
Anticancer Research 20 3545 -3548
8
2000
Production of MAGE-3 positive APC using a retroviral vector for the stimulation of TCR transduced T cells.
Geesiena Hospers , A Calogero , van Jacoba Zanten , Nanno Mulder
Journal of Leukocyte Biology 97 -97
1998
Comparison of [F-18]FHPG, [F-18]FMAU, [F-18]FLT and [F-18]FEAU as radiotracers for herpes simplex virus thymidine kinase (HSVtk) gene expression.
Geesiena Hospers , W Vaalburg , Nanno Mulder , AR Buursma
The Journal of Nuclear Medicine 44 ( 5)
2
2003
The influence of membrane transport and endogenous thymidine on the F-18-FHPG uptake in HSVtk expressing cells.
Geesiena Hospers , W Vaalburg , Nanno Mulder , AR Buursma
The Journal of Nuclear Medicine 43 ( 5)
2
2002
Hematopoëtische groeifactoren als ondersteunende behandeling bij agranulocytose als gevolg van gebruik van geneesmiddelen
Bouke Hazenberg , J T de Wolf , Edo Vellenga , Geesiena Hospers
Nederlands Tijdschrift voor Geneeskunde 137 ( 42)
1993
THE HUMAN NOREPINEPHRINE TRANSPORTER (hNET) IN COMBINATION WITH [C-11]m-HYDROXYEPHEDRINE ([C-11]mHED) AS REPORTER GENE/PROBE FOR GENE THERAPY
Geesiena Hospers , Marianne Rots , Marianne Rots , W. Vaalburg
Journal of Labelled Compounds and Radiopharmaceuticals 48
2005
Definitive (Chemo) Radiotherapy in Esophageal Cancer Patients : A Population-based Study in North-East Netherlands
J. A. Langendijk , G. A. Hospers , D. Woutersen , G. Paardekooper
Annals of Surgical Oncology 19
2012
A Comparison of Carboplatin with Paclitaxel and Cisplatinum with 5-fluorouracil in Definitive Chemoradiotherapy in Esophageal Cancer Patients
G. A. Hospers , J. C. Beukema , J. K. Smit , J. Honing
Annals of Surgical Oncology 21
2014
Towards clinical VEGF imaging using the anti-VEGF antibody bevacizumab and Fab-fragment ranibizumab
W. B. Nagengast , M. N. Lub-de Hooge , G. A. Hospers , A. H. Brouwers
Journal of Clinical Oncology 26 ( 15) 3547 -3547
7
2008
Effect of hospitals on survival and postoperative mortality of stomach cancer : A population-based study on type, referral, and volume-effect in the northeast Netherlands
E. Siemerink , M. Schaapveld , G. A. Hospers , N. H. Mulder
Journal of Clinical Oncology 27 ( 15)
2009
In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft
W. B. Nagengast , E. G. de Vries , G. A. Hospers , N. H. Mulder
The Journal of Nuclear Medicine 48 ( 8) 1313 -1319
265
2007
Use of S-100B to evaluate therapy effects during bevacizumab induction treatment in AJCC stage III melanoma.
A. J. H. Suurmeijer , G. A. Hospers , H. J. Hoekstra , S. Kruijff
Annals of Surgical Oncology 19 ( 2) 620 -626
15
2012
Preoperative chemoradiotherapy regimen with capecitabine and bevacizumab in locally advanced rectal cancer: A feasibility study of the Dutch Colorectal Cancer Group (DCCG)
C. A. Marijnen , H. Rutten , H. de Wilt , M. E. Tesselaar
Journal of Clinical Oncology 26 ( 15) 15040 -15040
16
2008
Early prediction of response to sorafenib treatment in patients with hepatocellular carcinoma (HCC) with 18F- fluorodeoxyglucose-positron emission tomography (18F-FDG-PET)
E. Siemerink , N. H. Mulder , A. H. Brouwers , G. A. Hospers
Journal of Clinical Oncology 26 ( 15) 15600 -15600
6
2008
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.
A. H. Boekhout , A. Rogiers , K. Jozwiak , M. J. Boers-Sonderen
Acta Oncologica 60 ( 1) 69 -77
8
2021
Survival of non-Western first generations immigrants with stomach cancer in North East Netherlands
E J M Siemerink , M A van der Aa , S Siesling , G A P Hospers
British Journal of Cancer 104 ( 7) 1193 -1195
3
2011
Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes.
A Calogero , H Timmer-Bosscha , H Schraffordt Koops , A T M G Tiebosch
British Journal of Cancer 83 ( 2) 184 -187
21
2000